Screener
Allogene Therapeutics ALLO Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
FAQ
- What is Allogene Therapeutics's operating lease liability payments due?
- Allogene Therapeutics (ALLO) reported operating lease liability payments due of $102.69M in Q1 2026.
- How has Allogene Therapeutics's operating lease liability payments due changed year-over-year?
- Allogene Therapeutics's operating lease liability payments due decreased by 11.4% year-over-year, from $115.94M to $102.69M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.
Ask your AI about Allogene Therapeutics's operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude